InsidersTradesSigma
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Explore the complete record of transactions filed by Schwartz Aharon. Director active across 1 company, notably Protalix BioTherapeutics, Inc.. Aggregated, 3 filings have been published. Breakdown: 2 buys · 0 sell. Total volume traded: €326k. Activity tracked since 3 January 2023. The latest transaction was filed on 10 June 2025 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条